Rigel Pharmaceuticals Inc. (New) RIGL

$42.45 -0.31% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-04 View →
10-Q 10-Q 2026-08-04 View →
4 FORM 4 2026-07-10 View →
8-K 8-K 2026-07-01 View →
4 FORM 4 2026-06-24 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
8-K 8-K 2026-06-17 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-05-28 View →
8-K 8-K 2026-05-20 View →
4 FORM 4 2026-05-19 View →
4 FORM 4 2026-05-19 View →
4 FORM 4 2026-05-19 View →
4 FORM 4 2026-05-19 View →
4 FORM 4 2026-05-19 View →
4 FORM 4 2026-05-19 View →
4 FORM 4 2026-05-19 View →
8-K 8-K 2026-05-12 View →
8-K 8-K 2026-05-05 View →
10-Q 10-Q 2026-05-05 View →
8-K 8-K 2026-04-21 View →
DEF 14A DEF 14A 2026-04-03 View →
8-K 8-K 2026-03-03 View →
10-K 10-K 2026-03-03 View →
4 FORM 4 2026-02-24 View →
4 FORM 4 2026-02-19 View →
4 FORM 4 2026-02-19 View →
4 FORM 4 2026-02-19 View →
4 FORM 4 2026-02-19 View →
4 FORM 4 2026-02-19 View →
4 FORM 4 2026-02-12 View →
4 FORM 4 2026-02-12 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$42.45
Market Cap
$795.39 million
52-Week Range
$18.65 – $52.24
Average Volume
338K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.